Anti-vaccine group that Robert F. Kennedy Jr. founded files suit against him over vaccine safety task force
'Our first priority will ALWAYS be children's health. Sec. Kennedy has FAILED 'to establish a task force dedicated to making childhood vaccines safer, as mandated by federal law,' so we WILL be holding him accountable,' Children's Health Defense said Tuesday in a post on X.
The National Childhood Vaccine Injury Act of 1986 directs the HHS secretary to establish a task force consisting of the director of the National Institutes of Health, the commissioner of the Food and Drug Administration and the director of the Centers for Disease Control and Prevention. The NIH director is designated as chair.
According to an article posted Monday on Children's Health Defense's news site, in the years since the act was passed, no HHS secretary – including Kennedy – has ever reported to Congress on steps taken to make vaccines safer.
'This is part of the 1986 act itself,' Children's Health Defense CEO Mary Holland said in the article. 'That no secretary has done so since the passage of this law is a blow to the rule of law. I hope and trust that the current secretary will fulfill his obligation to Congress's mandate.'
The organization says attorney Ray Flores, its senior outside counsel, filed the lawsuit on its behalf. Kennedy filed a similar case in 2018 after a Freedom of Information Act request failed to produce any of the reports that are supposed to be filed under the Act.
HHS has not responded to CNN's request for comment about the new lawsuit.
'Even if it does not include the people in the [National Childhood Vaccine Injury Act], there are multiple federal committees that routinely look at vaccine safety and how to make vaccines safer. It's something that gets a lot of attention,' Dorit Reiss, a professor of law at UC Law San Francisco, told CNN in an email.
'This looks performative, and it may give Kennedy cover for convening this task force that he may already want to convene. It may well be collusion,' she wrote. 'To me, this looks like a way to give political cover to something the Secretary may want to do anyway (and can do without anything). The government has answers to this lawsuit, but may not want to.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
17 minutes ago
- Yahoo
CareDx Announces Appointment of Nathan Smith as Chief Financial Officer
BRISBANE, Calif., August 06, 2025--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA), — The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced the appointment of Nathan Smith to the role of Chief Financial Officer. Nathan will lead key financial and accounting initiatives that are a part of the Company's long-term strategic growth plan. Nathan brings more than 14 years of experience in the molecular diagnostics industry, including senior finance leadership roles at Myriad Genetics and recent CFO positions at Blackrock Neurotech and WIN Brands. "Nathan's deep financial expertise in molecular diagnostics is a great fit for CareDx," said John Hanna, CEO of CareDx. "His track record of operational excellence and experience in supporting diagnostics companies to scale efficiently will be invaluable as we enter our next phase." In conjunction with this appointment, the Company also announced that Abhishek Jain will be retiring from his role as Chief Financial Officer. Abhishek will continue to support CareDx in a consulting capacity to ensure a seamless transition. "On behalf of the Board and the entire CareDx team, I want to express my sincere gratitude to Abhishek for his outstanding leadership as CFO," said John Hanna. "Abhishek's disciplined financial management, stewardship through our CEO transition, and dedication to strengthening our finance function have positioned CareDx for continued success. We wish him all the best." About CareDx CareDx, Inc., headquartered in Brisbane, California, is a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. For more information, visit Forward Looking Statements This press release includes forward-looking statements related to CareDx, Inc. These forward-looking statements are based upon information that is currently available to CareDx and its current expectations, speak only as of the date hereof, and are subject to risks and uncertainties that could cause actual results to differ materially from those projected, including general economic and market factors and other risks discussed in CareDx's filings with the SEC, including, but not limited to, the Annual Report on Form 10-K for the fiscal year ended December 31, 2024 filed by CareDx with the SEC on February 28, 2025, the Quarterly Report on Form 10-Q for the quarter ended March 31, 2025 filed by CareDx with the SEC on April 30, 2025, and other reports that CareDx has filed with the SEC. Any of these may cause CareDx's actual results, performance, or achievements to differ materially and adversely from those anticipated or implied by CareDx's forward-looking statements. You are cautioned not to place undue reliance on these forward-looking statements. CareDx expressly disclaims any obligation, except as required by law, or undertaking to update or revise any such forward-looking statements, whether as a result of new information, future events or otherwise. View source version on Contacts CareDx Media Contacts Natasha Moshirian Wagnernwagner@ Investor RelationsCaroline Cornerinvestor@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
17 minutes ago
- Yahoo
FDA flags problems with two Boston Scientific heart devices tied to injuries and deaths
WASHINGTON (AP) — U.S. health regulators are warning doctors and patients about safety issues with two separate Boston Scientific heart devices recently linked to injuries and deaths. The Food and Drug Administration issued two alerts Wednesday about electrical problems tied to the company's heart-zapping defibrillator systems and a separate issue with a heart implant used to reduce stroke risk. The agency said the company's Endotak Reliance defibrillator wires can become calcified, leading to failures in delivering life-saving shocks to the heart, according to the FDA. Defibrillators are surgically placed in the upper chest, where they monitor irregular heartbeats and use electrical shocks to jolt the heart back to normal. As of July 24, Boston Scientific has reported 386 serious injuries and 16 deaths associated with this issue, the agency said. Ten of the deaths were judged to be due to the device failing to function properly, the company said in an email. Four were linked to attempts to surgically remove the devices from patients and two others were deemed unrelated to the implants. Boston Scientific's wires were distributed between 2002 and 2021 and are no longer available, the company noted in its letter to doctors. Some patients will need to have the devices replaced, though physicians should weigh the risks of the removal procedure. In a separate notice, the FDA said Boston Scientific recently updated instructions for implanting its Watchman device, which closes a portion of the heart's left atrium to reduce the risk of stroke. In a letter to physicians, the company noted that there is an increased risk of blockages in the bloodstream depending on the level of anesthesia for patients undergoing the initial implantation procedure. Watchman is an alternative to long-term treatment with blood thinners for patients at increased risk of stroke. As of July 30, the company has reported 120 serious injuries and 17 deaths related to the issue, the FDA said. A company investigation concluded that the safety issue 'is not associated with the design or manufacture of any component of the Watchman system. Heart devices, including defibrillators and other implants, are Boston Scientific's largest business, making up two-thirds of its $5 billion in revenue for the most recent quarter. Shares of Boston Scientific Corp. fell nearly 1.8 percent Wednesday to close at $102.95 in trading. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.


Vox
19 minutes ago
- Vox
RFK Jr. defunds a medical miracle
This story appeared in The Logoff, a daily newsletter that helps you stay informed about the Trump administration without letting political news take over your life. Subscribe here. Welcome to The Logoff: In a blow to US pandemic preparedness, Health Secretary Robert F. Kennedy Jr. announced on Tuesday evening that he was slashing $500 million in federal mRNA vaccine contracts. What is HHS cutting? Twenty-two mRNA vaccine projects, intended to combat respiratory viruses like bird flu, are set to be wound down following the announcement. What is mRNA? mRNA, or messenger RNA, is the reason the US had safe, effective Covid-19 vaccines available as early as it did. A promising but still unproven technology prior to the pandemic, mRNA allowed pharmaceutical companies to develop effective vaccines far more rapidly and more adaptably than was once possible. Beyond respiratory viruses like Covid, researchers hope mRNA could even be effective in treating cancers. What's the context? Kennedy has long made false claims about mRNA vaccines, including describing the Covid-19 vaccine as 'the deadliest vaccine ever made.' On Tuesday, he falsely stated that mRNA vaccines 'don't perform well against viruses that infect the upper respiratory tract,' such as Covid. In fact, by one estimate, the Covid vaccines saved some 2.5 million lives. The Logoff The email you need to stay informed about Trump — without letting the news take over your life. Email (required) Sign Up By submitting your email, you agree to our Terms and Privacy Notice . This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. What are the implications of the cuts? Tuesday's announcement is bad news for two distinct reasons. As far as Kennedy is concerned, this is just the latest reminder that he is who he always appeared to be, and only partially covered up while seeking to be confirmed as the secretary for the US Department of Health and Human Services: not a fair 'skeptic' but an anti-vaccine advocate who will use his power to impose unscientific beliefs on US public health infrastructure. For the country, vaccine experts say Tuesday's news is a real blow to efforts to prepare for the next pandemic, the arrival of which is a question of when and not if. mRNA vaccines have proved to be one of our best tools for saving lives, and the US will now be further behind in developing new vaccines than it otherwise would be. The consequence is likely to be measured in human lives. And with that, it's time to log off…